EP2185560A4 - Heteroarylamidanaloge - Google Patents
HeteroarylamidanalogeInfo
- Publication number
- EP2185560A4 EP2185560A4 EP08797591A EP08797591A EP2185560A4 EP 2185560 A4 EP2185560 A4 EP 2185560A4 EP 08797591 A EP08797591 A EP 08797591A EP 08797591 A EP08797591 A EP 08797591A EP 2185560 A4 EP2185560 A4 EP 2185560A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- heteroaryl amide
- amide analogues
- analogues
- heteroaryl
- amide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95525007P | 2007-08-10 | 2007-08-10 | |
PCT/US2008/072760 WO2009023623A1 (en) | 2007-08-10 | 2008-08-11 | Heteroaryl amide analogues |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2185560A1 EP2185560A1 (de) | 2010-05-19 |
EP2185560A4 true EP2185560A4 (de) | 2011-10-05 |
Family
ID=40351102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08797591A Withdrawn EP2185560A4 (de) | 2007-08-10 | 2008-08-11 | Heteroarylamidanaloge |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP2185560A4 (de) |
JP (2) | JP2010535816A (de) |
KR (1) | KR20100066422A (de) |
CN (1) | CN101778850A (de) |
AU (1) | AU2008286946B2 (de) |
BR (1) | BRPI0812594A2 (de) |
CA (1) | CA2691512A1 (de) |
CO (1) | CO6251319A2 (de) |
EA (1) | EA020332B1 (de) |
IL (1) | IL202550A0 (de) |
NZ (1) | NZ582056A (de) |
SG (1) | SG183699A1 (de) |
UA (1) | UA99729C2 (de) |
WO (1) | WO2009023623A1 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2010237302A1 (en) * | 2009-04-14 | 2011-12-01 | Affectis Pharmaceuticals Ag | Novel P2X7R antagonists and their use |
WO2012110190A1 (en) * | 2011-02-17 | 2012-08-23 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
DK2707101T3 (da) | 2011-05-12 | 2019-05-13 | Proteostasis Therapeutics Inc | Proteostaseregulatorer |
WO2012163456A1 (en) * | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
WO2012163792A1 (en) * | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
ES2574840T3 (es) | 2011-07-22 | 2016-06-22 | Actelion Pharmaceuticals Ltd. | Derivados de amidas heterocíclicas como antagonistas de receptores p2x7 |
NZ628910A (en) * | 2012-01-20 | 2016-02-26 | Actelion Pharmaceuticals Ltd | Heterocyclic amide derivatives as p2x7 receptor antagonists |
JOP20130213B1 (ar) * | 2012-07-17 | 2021-08-17 | Takeda Pharmaceuticals Co | معارضات لمستقبلht3-5 |
ES2618056T3 (es) | 2012-12-12 | 2017-06-20 | Actelion Pharmaceuticals Ltd. | Derivados de indol carboxamida como antagonistas del receptor P2X7 |
AR094053A1 (es) * | 2012-12-18 | 2015-07-08 | Actelion Pharmaceuticals Ltd | Derivados de indol carboxamida como antagonistas del receptor p2x₇ |
ES2616114T3 (es) | 2013-01-22 | 2017-06-09 | Actelion Pharmaceuticals Ltd. | Derivados de amida heterocíclica como antagonistas del receptor P2X7 |
WO2014115078A1 (en) | 2013-01-22 | 2014-07-31 | Actelion Pharmaceuticals Ltd | Heterocyclic amide derivatives as p2x7 receptor antagonists |
MX2015010714A (es) | 2013-02-19 | 2016-06-14 | Pfizer | Compuestos de azabencimidazol. |
TWI627174B (zh) | 2013-03-14 | 2018-06-21 | 比利時商健生藥品公司 | P2x7調控劑 |
TWI599567B (zh) | 2013-03-14 | 2017-09-21 | 健生藥品公司 | P2x7調節劑 |
US9096596B2 (en) | 2013-03-14 | 2015-08-04 | Janssen Pharmaceutica Nv | P2X7 modulators |
US9040534B2 (en) | 2013-03-14 | 2015-05-26 | Janssen Pharmaceutica Nv | [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators |
ES2644025T3 (es) * | 2013-07-17 | 2017-11-27 | Global Alliance For Tb Drug Development | Compuestos de azaindol, síntesis de los mismos, y procedimientos de uso de los mismos |
GB201317363D0 (en) | 2013-10-01 | 2013-11-13 | Eisai Ltd | Novel compounds |
WO2015073528A1 (en) | 2013-11-12 | 2015-05-21 | Proteostasis Therapeutics, Inc. | Proteasome activity enhancing compounds |
EP3172210B1 (de) | 2014-07-24 | 2020-01-15 | Pfizer Inc | Pyrazolopyrimidin verbindungen |
KR102061952B1 (ko) | 2014-08-06 | 2020-01-02 | 화이자 인코포레이티드 | 이미다조피리다진 화합물 |
EA034015B1 (ru) | 2014-09-12 | 2019-12-19 | Янссен Фармацевтика Нв | Модуляторы р2х7 |
PL3201203T3 (pl) | 2014-09-29 | 2021-11-22 | Takeda Pharmaceutical Company Limited | Krystaliczna postać 1-(1-metylo-1h-pirazol-4-ilo)-n-((1r,5s,7s)-9-metylo-3-oksa-9-azabicyklo[3.3.1]nonan-7-ylo)-1h-indolo-3-karboksyamidu |
WO2016100281A1 (en) * | 2014-12-15 | 2016-06-23 | Merck Patent Gmbh | Indole and azaindoles derivatives and their use in neurodegenerative diseases |
JP6462493B2 (ja) | 2015-05-29 | 2019-01-30 | 株式会社デンソー | 進入判定装置、進入判定方法 |
CA3010615C (en) | 2016-01-14 | 2024-02-20 | Beth Israel Deaconess Medical Center, Inc. | Mast-cell modulators and uses thereof |
TW201819361A (zh) | 2016-09-03 | 2018-06-01 | 印度商托仁特生技有限公司 | 新穎吲唑化合物 |
KR20210069080A (ko) | 2018-09-28 | 2021-06-10 | 얀센 파마슈티카 엔.브이. | 모노아실글리세롤 리파아제 조절제 |
WO2020065614A1 (en) | 2018-09-28 | 2020-04-02 | Janssen Pharmaceutica Nv | Monoacylglycerol lipase modulators |
CN114555596A (zh) | 2019-09-30 | 2022-05-27 | 詹森药业有限公司 | 放射性标记的mgl pet配体 |
JP2023518511A (ja) | 2020-03-26 | 2023-05-01 | ヤンセン ファーマシューティカ エヌ.ベー. | モノアシルグリセロールリパーゼ調節因子 |
CN116323581A (zh) * | 2020-09-22 | 2023-06-23 | 苏州恩华生物医药科技有限公司 | 吲哚衍生物及其应用 |
WO2023198199A1 (zh) * | 2022-04-15 | 2023-10-19 | 先声再明医药有限公司 | 膜缔合酪氨酸和苏氨酸激酶抑制剂 |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4374846A (en) * | 1979-08-02 | 1983-02-22 | Kali-Chemie Pharma Gmbh | N-Amino alkyl indole compounds compositions containing same, and a method of using same in therapy of disorders of gastrointestinal motility |
US4803198A (en) * | 1981-08-08 | 1989-02-07 | Kali-Chemie Pharma Gmbh | 1-Phenyl-2-aminocarbonylindole compounds, preparation thereof and pharmaceutical compositions containing them |
US5399559A (en) * | 1992-06-05 | 1995-03-21 | Shell Research Limited | Fungicidal indole derivatives |
US5424329A (en) * | 1993-08-18 | 1995-06-13 | Warner-Lambert Company | Indole-2-carboxamides as inhibitors of cell adhesion |
EP1310488A1 (de) * | 2000-08-09 | 2003-05-14 | Mitsubishi Pharma Corporation | Kondensierte bizyklische amidverbindungen und ihre medizinische verwendung |
US20030199689A1 (en) * | 2001-11-22 | 2003-10-23 | Marc Nazare | New indole derivatives as factor Xa inhibitors |
WO2004056768A2 (en) * | 2002-12-20 | 2004-07-08 | Bayer Healthcare Ag | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
WO2005009947A2 (fr) * | 2003-07-24 | 2005-02-03 | Aventis Pharma S.A. | Produits aryl-heteroaromatiques, compositions les contenant et utilisation |
WO2005014529A1 (en) * | 2003-08-08 | 2005-02-17 | Astrazeneca Ab | 2- adamantyl derivatives as p2x7 receptor antagonists. |
US20050165049A1 (en) * | 2004-01-23 | 2005-07-28 | Christopher Hulme | Vanilloid receptor ligands and their use in treatments |
WO2006072736A1 (fr) * | 2005-01-07 | 2006-07-13 | Sanofi-Aventis | DERIVES DE N- (HETEROARYL) -1H-IND0LE-2-CARB0XAMIDΞS ET LEUR UTILISATION COMME LIGANDS DU RECEPTEUR VANILLOIDE TRPVl |
WO2006100208A1 (en) * | 2005-03-21 | 2006-09-28 | N.V. Organon | 1-benzylindole-2-carboxamide derivatives |
US20070149602A1 (en) * | 2004-08-05 | 2007-06-28 | Sanofi-Aventis | N-(1h-indolyl)-1h-indole-2-carboxamide derivatives, their preparation and their therapeutic use |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2557342A1 (de) * | 1975-12-19 | 1977-06-30 | Hoechst Ag | Basisch substituierte indolderivate und verfahren zu ihrer herstellung |
US5023265A (en) * | 1990-06-01 | 1991-06-11 | Schering Corporation | Substituted 1-H-pyrrolopyridine-3-carboxamides |
RU2225397C2 (ru) * | 1997-12-24 | 2004-03-10 | Авентис Фарма Дойчланд Гмбх | Производные индола как ингибиторы фактора Ха |
JP2002541249A (ja) * | 1999-04-09 | 2002-12-03 | アストラゼネカ・アクチエボラーグ | アダマンタン誘導体 |
MXPA02003436A (es) * | 1999-10-07 | 2002-08-20 | Amgen Inc | Inhibidores de triazina cinasa. |
JP2004502642A (ja) * | 2000-02-11 | 2004-01-29 | ブリストル−マイヤーズ スクイブ カンパニー | カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用 |
CN1551866A (zh) * | 2001-08-09 | 2004-12-01 | СҰҩƷ��ҵ��ʽ���� | 羧酸衍生物化合物及包含这些化合物为活性成分的药物 |
DE60316709T2 (de) * | 2002-10-03 | 2008-07-17 | F. Hoffmann-La Roche Ag | Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren |
DE10253426B4 (de) * | 2002-11-15 | 2005-09-22 | Elbion Ag | Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung |
FR2888847B1 (fr) * | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique |
WO2007079239A2 (en) * | 2005-12-30 | 2007-07-12 | Acadia Pharmaceuticals Inc. | Bicyclic nitrogen compounds as modulators of ghrelin receptor and uses thereof |
JP2009527562A (ja) * | 2006-02-21 | 2009-07-30 | アムゲン インコーポレイティッド | ホスホジエステラーゼ10阻害剤としてのシンノリン誘導体 |
-
2008
- 2008-08-11 EP EP08797591A patent/EP2185560A4/de not_active Withdrawn
- 2008-08-11 UA UAA200913336A patent/UA99729C2/ru unknown
- 2008-08-11 KR KR1020097026704A patent/KR20100066422A/ko not_active Application Discontinuation
- 2008-08-11 CA CA002691512A patent/CA2691512A1/en not_active Abandoned
- 2008-08-11 WO PCT/US2008/072760 patent/WO2009023623A1/en active Application Filing
- 2008-08-11 EA EA200971085A patent/EA020332B1/ru not_active IP Right Cessation
- 2008-08-11 BR BRPI0812594-5A patent/BRPI0812594A2/pt not_active IP Right Cessation
- 2008-08-11 JP JP2010520343A patent/JP2010535816A/ja not_active Ceased
- 2008-08-11 SG SG2012058533A patent/SG183699A1/en unknown
- 2008-08-11 AU AU2008286946A patent/AU2008286946B2/en not_active Ceased
- 2008-08-11 NZ NZ582056A patent/NZ582056A/xx not_active IP Right Cessation
- 2008-08-11 CN CN200880021498A patent/CN101778850A/zh active Pending
-
2009
- 2009-12-06 IL IL202550A patent/IL202550A0/en unknown
- 2009-12-22 CO CO09146587A patent/CO6251319A2/es not_active Application Discontinuation
-
2014
- 2014-11-25 JP JP2014238138A patent/JP2015110566A/ja active Pending
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4374846A (en) * | 1979-08-02 | 1983-02-22 | Kali-Chemie Pharma Gmbh | N-Amino alkyl indole compounds compositions containing same, and a method of using same in therapy of disorders of gastrointestinal motility |
US4803198A (en) * | 1981-08-08 | 1989-02-07 | Kali-Chemie Pharma Gmbh | 1-Phenyl-2-aminocarbonylindole compounds, preparation thereof and pharmaceutical compositions containing them |
US5399559A (en) * | 1992-06-05 | 1995-03-21 | Shell Research Limited | Fungicidal indole derivatives |
US5424329A (en) * | 1993-08-18 | 1995-06-13 | Warner-Lambert Company | Indole-2-carboxamides as inhibitors of cell adhesion |
EP1310488A1 (de) * | 2000-08-09 | 2003-05-14 | Mitsubishi Pharma Corporation | Kondensierte bizyklische amidverbindungen und ihre medizinische verwendung |
US20030199689A1 (en) * | 2001-11-22 | 2003-10-23 | Marc Nazare | New indole derivatives as factor Xa inhibitors |
WO2004056768A2 (en) * | 2002-12-20 | 2004-07-08 | Bayer Healthcare Ag | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
WO2005009947A2 (fr) * | 2003-07-24 | 2005-02-03 | Aventis Pharma S.A. | Produits aryl-heteroaromatiques, compositions les contenant et utilisation |
WO2005014529A1 (en) * | 2003-08-08 | 2005-02-17 | Astrazeneca Ab | 2- adamantyl derivatives as p2x7 receptor antagonists. |
US20050165049A1 (en) * | 2004-01-23 | 2005-07-28 | Christopher Hulme | Vanilloid receptor ligands and their use in treatments |
US20070149602A1 (en) * | 2004-08-05 | 2007-06-28 | Sanofi-Aventis | N-(1h-indolyl)-1h-indole-2-carboxamide derivatives, their preparation and their therapeutic use |
WO2006072736A1 (fr) * | 2005-01-07 | 2006-07-13 | Sanofi-Aventis | DERIVES DE N- (HETEROARYL) -1H-IND0LE-2-CARB0XAMIDΞS ET LEUR UTILISATION COMME LIGANDS DU RECEPTEUR VANILLOIDE TRPVl |
WO2006100208A1 (en) * | 2005-03-21 | 2006-09-28 | N.V. Organon | 1-benzylindole-2-carboxamide derivatives |
Non-Patent Citations (6)
Title |
---|
BRANDS ET AL.: "Novel, selective indole-based ECE inhibitors: Lead optimization via solid-phase and classical synthesis", BIOORG. MED. CHEM. LETT., vol. 15, no. 19, 1 October 2005 (2005-10-01), pages 4201 - 4205, XP027388767, ISSN: 0960-894X, [retrieved on 20050830] * |
CONNOR ET AL.: "Novel Benzothiophene-, Benzofuran-, and Naphthalenecarboxamidotetraz oles as Potential Antiallergy Agents", J. MED. CHEM., vol. 35, 1 January 1992 (1992-01-01), pages 958 - 965, XP002303235, ISSN: 0022-2623, DOI: 10.1021/JM00083A023 * |
NAZARE ET AL.: "Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituents", BIOORG. MED. CHEM. LETT., vol. 14, no. 16, 1 May 2004 (2004-05-01), pages 4191 - 4195, XP002546716, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2004.06.020 * |
NAZARE ET AL.: "Probing the Subpockets of Factor Xa Reveals Two Binding Modes for Inhibitors Based on a 2-Carboxyindole Scaffold: A Study Combining Structure-Activity Relationship and X-ray Crystallography", J. MED. CHEM., vol. 48, no. 14, 1 January 2005 (2005-01-01), pages 4511 - 4525, XP002546715, ISSN: 0022-2623, [retrieved on 20050611], DOI: 10.1021/JM0490540 * |
OELGEN ET AL.: "Synthesis and antioxidant properties of novel N-substituted indole-2-carboxamide and indole-3-acetamide derivatives", ARCHIV DER PHARMAZIE, vol. 7, 1 January 2002 (2002-01-01), pages 331 - 338, XP002275101, ISSN: 0365-6233, DOI: 10.1002/1521-4184(200209)335:7<331::AID-ARDP331>3.0.CO;2-7 * |
See also references of WO2009023623A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009023623A1 (en) | 2009-02-19 |
EA200971085A1 (ru) | 2010-06-30 |
EA020332B1 (ru) | 2014-10-30 |
BRPI0812594A2 (pt) | 2015-06-23 |
JP2015110566A (ja) | 2015-06-18 |
KR20100066422A (ko) | 2010-06-17 |
AU2008286946A1 (en) | 2009-02-19 |
CN101778850A (zh) | 2010-07-14 |
JP2010535816A (ja) | 2010-11-25 |
NZ582056A (en) | 2012-08-31 |
CA2691512A1 (en) | 2009-02-19 |
UA99729C2 (en) | 2012-09-25 |
AU2008286946B2 (en) | 2013-11-21 |
EP2185560A1 (de) | 2010-05-19 |
IL202550A0 (en) | 2010-06-30 |
CO6251319A2 (es) | 2011-02-21 |
SG183699A1 (en) | 2012-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL202550A0 (en) | Heteroaryl amide analogues | |
IL201356A0 (en) | Heteroaryl amide amide analogues as p2x7 antagonists | |
EP2172447A4 (de) | Amidverbindung | |
IL204970A0 (en) | Amide compound | |
EP2044055A4 (de) | Amidverbindungen | |
ZA201007686B (en) | Amide compound | |
EP2298731A4 (de) | Amidverbindung | |
IL198827A0 (en) | Heteroaryl amide derivatives | |
IL192960A0 (en) | Heteroaroyl-substituted alanines | |
AP2009004853A0 (en) | Improved reciprocating devices | |
EP2125920A4 (de) | Hochfunktionelle aminverbindungen und ihre verwendung | |
HRP20140047T1 (en) | Cycloptopyl amide derivatives | |
HK1139029A1 (en) | Cable-free arthroendoscope | |
EP2119702A4 (de) | Amidderivat | |
EP2123666A4 (de) | Peptid | |
GB0602621D0 (en) | Fastening | |
GB0703945D0 (en) | Peptide | |
GB0702547D0 (en) | Elevation | |
HK1156630A1 (en) | Schweinfurthin analogues schweinfurthin | |
ZA200708752B (en) | Component | |
GB0720507D0 (en) | Amide addition reaction | |
GB0810243D0 (en) | Amide derivatives | |
GB0614831D0 (en) | Amide derivatives | |
GB0718494D0 (en) | MUulti-function extension | |
GB0715691D0 (en) | Hair-we-grwo extension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100310 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: YUAN, JUN Inventor name: WUSTROW, DAVID J. Inventor name: CAPITOSTI, SCOTT M. Inventor name: IHLE, DAVID C. Inventor name: BAKTHAVATCHALAM, RAJAGOPAL |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20110905 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/02 20060101ALI20110830BHEP Ipc: A61K 31/506 20060101ALI20110830BHEP Ipc: C07D 471/04 20060101ALI20110830BHEP Ipc: C07D 403/04 20060101ALI20110830BHEP Ipc: C07D 401/14 20060101ALI20110830BHEP Ipc: C07D 401/12 20060101ALI20110830BHEP Ipc: C07D 401/04 20060101AFI20110830BHEP |
|
17Q | First examination report despatched |
Effective date: 20140328 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20141008 |